Memotex tmh2011

www.memotext.com
1877-MEMO.TXT
Twitter @memotext
MEMOTEXT Corporation Trial with Johns Hopkins University
Wilmer Eye Clinic –
Funded by Microsoft BeWell Fund
Study Title: The Impact of Automated Reminders Linked to a Personal Health Record on Adherence with Glaucoma Medications: The Automated Dosing Reminder Study (ADRS)

What Really Works?!
What is MEMOTEXT?
Overview: Automated Dosing Reminder Study (ADRS)
Problem/Hypothesis
Methods
Moving the Needle
Lessons Learned ~ Organic solutions
2

What is MEMOTEXT?
RE-ASSESSMENT
MEMOTEXT is an:
Iterative methodology
Interactive dialogue
Inference based
…speech, mobile and social media patient adherence solution.
3 of 10

What really works?!
www.memotext.com
Johns Hopkins University: Approached MEMOTEXT® to provide an automated, customized and interactive adherence solution for glaucoma daily medication - a study entitled "The Impact of Automated Dosing Reminders on Medication Adherence using HealthVault“ (ADRS).
Launched: June 2009
Prelim results presented at American Glaucoma Society March 2011
Automated reminders linked to a personal health record are a practical option to improve adherence
This project received funding from the Microsoft HealthVault Be Well Fund.
Lead by: Michael V. Boland, MD, PhD
Assistant Professor
Director of Information Technology
Wilmer Eye Institute and Health Sciences Informatics
Johns Hopkins University
4 of 10

Glaucoma adherence study overview
www.memotext.com
Problem:
Non-compliance to Glaucoma medications leads to severe complications.
Problem: cost- staff time to interact with patients
Problem: lack of patient education
Problem: poor adherence in almost half of study patients
Problem: patients self –reporting after the fact is not reliable
Problem: Lack of patient/family control
Hypothesis:
The Automated Dosing Reminder Study tested the hypothesis that automated, telecommunication-based reminders can improve adherence with glaucoma medications in patients known to have poor adherence.
5 of 10

Methods
www.memotext.com
Recruitment Channel: JHU Research / Wilmer Eye Clinic directly into Microsoft HealthVault
Poor adherence is defined as taking < 75% of doses during the monitored period.
N= 428glaucoma patients treated with once daily therapy.
Subjects were monitored electronically for 3 months (MEMS, AARDEX group).
White coat effect: adherence rate was calculated from 2 weeks after the baseline visit until 2 weeks before the follow-up visit.
6 of 10

Methods cont.. enrolment
www.memotext.com
Recruitment/Enrolment
Patients selected
Medication: Travatan, Xalatan and Lumigan
Frequency (daily/weekly)
Media (sms/IVR)
Time of message(s)
7 of 10

SMS and IVR Calls
49.02 % of voice messages were conf./acknowledged in real time.
2% of calls were snoozed and called back.
Patients receive weekly, bi-weekly or daily messages via voice / SMS
Acknowledge / confirm action
Snooze call
Repeat this message
8 of 10

Moving the needle
9 of 10

Summary…From simple messaging to intelligent dialogues.
Medication adherence is a problem in a significant population of glaucoma patients
Automated reminders linked to a personal health record:
Are a practical option to improve adherence
Allow patient or family control over reminders
Significantly improve adherence with daily medications
A simple, elegant intervention increased adherence by 16%
Recommendation was to develop method to predict non-adherent patients.
Do the difficult things while they are easy and do the great things while they are small... Lao Tzu
10 of 10

Find us to learn about how we create self-learning SMS, speech and social adherence interventions.
www.memotext.com
amos@memotext.com
www.Twitter.com/memotext
877-MEMO.TXT
Txt or call me: 416-520-3301
Keep in touch!
And they all lived happily ever after…

http://mobilehealth.org	413
http://curiousspectacle.com	22

Memotex tmh2011

by Mobile Health at Stanford on May 09, 2011

Accessibility

Categories

Upload Details

Usage Rights

2 Embeds 435

Statistics

Memotex tmh2011 — Presentation Transcript